文献速递神经MR

分子型胶质母细胞瘤的MRI形态学与高级成像特征

MRI features of molecular glioblastoma: morphological and advanced imaging insights.
PubMed 文献 · Eur J Radiol · 2026-01-23

回顾性分析72例经组织分子学确诊的分子型胶质母细胞瘤患者的1.5T或3T MRI,由两名神经放射科医生评估形态学及扩散、灌注特征。结果显示其MRI表现谱广,常类似低级别胶质瘤,但浸润性FLAIR高信号、多叶受累、扩散受限或灌注增高应提示诊断。

要点

  • 分子型胶质母细胞瘤MRI表现谱广,39%类似2级、26%类似4级,易被低估。
  • 浸润性FLAIR高信号、多叶受累、扩散受限或rCBV增高应警惕本病。
  • 老年患者出现类似低级别胶质瘤的浸润性病灶时需考虑分子型胶质母细胞瘤可能。

核心结论

  • 分子型胶质母细胞瘤常类似低级别胶质瘤,存在诊断不足和治疗延迟风险。
  • 浸润性FLAIR异常、多叶受累、扩散受限或灌注增高应提高对本病的怀疑,尤其在老年患者中。

研究设计与样本

  • 回顾性研究,纳入72例经组织分子学确诊的分子型胶质母细胞瘤患者。
  • 使用1.5T或3T MRI,由两名神经放射科医生分析形态学特征及扩散、灌注等高级成像表现。

关键影像表现/征象

  • 浸润性FLAIR高信号几乎恒存在,65%病例伴多叶受累。
  • 39%病例无明显对比增强,或增强微弱而局限,常类似较低级别胶质瘤。
  • 15%病例可见回形皮质浸润而白质相对不受累。
  • 64%病例出现扩散受限。

诊断标准与关键数值

  • 88%有灌注数据的病例rCBV增高,阈值为大于1.75。
  • 形态学类似2级的病灶中22%经高级成像重新分类为类似3级。
  • 39%病例表现为类似2级,26%表现为类似4级。

临床应用与阅片要点

  • 阅片时对缺乏强化但呈浸润性FLAIR高信号并伴多叶受累的病灶,不要轻易诊断为低级别胶质瘤。
  • 对形态学类似低级别的病灶应加做扩散和灌注成像,扩散受限或rCBV大于1.75提示高级别可能。
  • 老年患者的浸润性FLAIR异常即使无强化也应将分子型胶质母细胞瘤纳入鉴别。

局限性

  • 回顾性研究设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: IDH-wildtype diffuse gliomas with molecular features of glioblastoma (mGBM) were integrated into the GBM category in the 2021 WHO classification, yet their MRI characteristics remain poorly described. This study aimed to detail morphological and advanced MRI features of mGBM to improve diagnostic accuracy and management.

METHODS: MRI scans (1.5 T or 3 T) of 72 patients with histomolecularly confirmed mGBM were retrospectively reviewed. Two neuroradiologists analyzed morphological features (necrosis, contrast enhancement, FLAIR pattern, multilobar involvement) and advanced imaging findings (diffusion, perfusion).

RESULTS: Mean patient age was 63 years. mGBMs showed a broad spectrum of MRI appearances, from grade 2-like (39%) to grade 4-like (26%). Infiltrative FLAIR hyperintensity was nearly constant, frequently with multilobar involvement (65%). Contrast enhancement was absent in 39% or faint/limited when present, often mimicking lower-grade gliomas. Gyriform cortical infiltration sparing white matter was seen in 15% of cases, less than previously reported. Advanced imaging showed diffusion restriction in 64% and elevated rCBV (>1.75) in 88% of cases with perfusion data, leading to reclassification of 22% of morphologically grade 2-like lesions as grade 3-like.

CONCLUSION: mGBMs often mimic low-grade gliomas, exposing patients to underdiagnosis and treatment delays. However, infiltrative FLAIR abnormalities, multilobar involvement, diffusion restriction, or increased perfusion should raise suspicion, particularly in older patients. This cohort describing both morphological and advanced MRI features of mGBM provides practical imaging criteria to enhance early recognition in routine practice.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Roques, Pimentel, Siegfried-Vergnon, et al. MRI features of molecular glioblastoma: morphological and advanced imaging insights. Eur J Radiol. 2026. PMID: 41619575. doi:10.1016/j.ejrad.2026.112692

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。